S Yamagishi
Overview
Explore the profile of S Yamagishi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
283
Citations
3895
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Iijima Y, Iwai S, Yamagata A, Motono N, Usuda K, Yamagishi S, et al.
Clin Transl Oncol
. 2021 Jan;
23(8):1585-1592.
PMID: 33502740
Purpose: This study aimed to determine the outcomes and prognostic factors associated with octogenarians who underwent pulmonary resection for lung cancer. Methods/patients: From 2009 to 2018, 76 octogenarians underwent pulmonary...
2.
Ishibashi Y, Matsui T, Taira J, Higashimoto Y, Yamagishi S
Horm Metab Res
. 2016 May;
48(9):613-9.
PMID: 27214310
Pigment epithelium-derived factor (PEDF) is a glycoprotein with complex neuroprotective, anti-angiogenic, and anti-inflammatory properties, all of which could potentially be exploited as a therapeutic option for vascular complications in diabetes....
3.
Ishibashi Y, Matsui T, Yamagishi S
Horm Metab Res
. 2015 Jul;
48(3):191-5.
PMID: 26158396
Ninety percent of glucose filtered by the glomerulus is reabsorbed by a sodium-glucose cotransporter 2 (SGLT2), which is mainly expressed on S1 and S2 segment of renal proximal tubules. Since...
4.
Ishibe A, Ota M, Kanazawa A, Watanabe J, Tatsumi K, Watanabe K, et al.
Hepatogastroenterology
. 2015 Apr;
62(137):30-3.
PMID: 25911862
Background/aims: Anastomotic leakage is major complication of colorectal surgery. Total parenteral nutrition (TPN) and fasting are conservative treatments for leakage in the absence of peritonitis in Japan. Elemental diet (ED)...
5.
Takeuchi M, Sakasai-Sakai A, Takata T, Ueda T, Takino J, Tsutsumi M, et al.
Med Hypotheses
. 2015 Feb;
84(5):490-3.
PMID: 25697114
Nonalcoholic fatty liver disease (NAFLD) ranges from simple steatosis to nonalcoholic steatohepatitis (NASH), leads to fibrosis and potentially cirrhosis, liver failure, and hepatocellular carcinoma, and is one of the most...
6.
Ojima A, Matsui T, Nishino Y, Nakamura N, Yamagishi S
Horm Metab Res
. 2015 Jan;
47(9):686-92.
PMID: 25611208
Advanced glycation end products (AGEs) and receptor RAGE play a role in diabetic nephropathy. We have previously shown that increased glucose uptake into proximal tubular cells via sodium-glucose cotransporter 2...
7.
Ishibashi Y, Matsui T, Ueda S, Fukami K, Okuda S, Ohta H, et al.
Climacteric
. 2014 Oct;
18(3):426-30.
PMID: 25340263
Advanced glycation endproducts (AGEs) and their receptor (RAGE) play a role in vascular complications in diabetes. We have previously shown that 17β-estradiol at 10 nmol/l, a nearly identical plasma concentration...
8.
Ojima A, Matsui T, Nakamura N, Higashimoto Y, Ueda S, Fukami K, et al.
Horm Metab Res
. 2014 Aug;
47(4):253-8.
PMID: 25105541
Advanced glycation end products (AGEs) decrease adiponectin expression and suppress insulin signaling in cultured adipocytes through the interaction with a receptor for AGEs (RAGE) via oxidative stress generation. We have...
9.
Tsuji T, Ishiguro Y, Nakui Y, Murata Y, Munakata A, Onozuka N, et al.
Mod Rheumatol
. 2014 Jan;
11(3):238-41.
PMID: 24383733
Abstract A 46-year-old woman with systemic lupus erythematosus (SLE) was admitted owing to a sudden severe back pain. She had been receiving corticosteroids throughout the course of long-standing nephritis, and...
10.
Ishibashi Y, Matsui T, Yamagishi S
Horm Metab Res
. 2013 Dec;
46(6):379-83.
PMID: 24297485
Advanced glycation end products (AGEs) and their receptor (RAGE) system are involved in diabetic nephropathy. Angiotensin-converting enzyme 2 (ACE 2) plays a protective role against cardiovascular and renal injury by...